No Data
No Data
PetIQ | 10-Q: Quarterly report
Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (GDRX), Petiq (PETQ) and Biodesix (BDSX)
Oppenheimer Sticks to Their Hold Rating for Petiq (PETQ)
Q1 2024 PetIQ Inc Earnings Call
PetIQ Expects Q2 Net Sales Of $325M-$335M (Est $335.976M), Raises FY24 Forecast From $1.130B-$1.180B To $1.135B-$1.185B (Est $1.149B)
For the second quarter of 2024 the Company expects: Adjusted EBITDA of $34.0 million to $36.0 million.For the full year 2024 the Company expects: Adjusted EBITDA of $112.0 million to $118.0 million.
Express News | PetIQ Inc Sees Q2 Adjusted Ebitda of $34.0 Million to $36.0 Million